Matteo Pecoraro

Università della Svizzera italiana — Switzerland

Medicine · Health Sciences

13h-index2.0kcitations48works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(11), Immune Cell Function and Interaction(9), Immunotherapy and Immune Responses(7), CAR-T cell therapy research(7), RNA Research and Splicing(5)

Publications48 total

Abstract B076: TRIM24 degradation counteracts adaptation to androgen receptor inhibition in prostate cancer
Cancer Research·2026Open Access
Abstract PR020: Targeting of FOXA1 and FOXA2 by small molecules disables the oncogenic output of castration resistant prostate cancer
Cancer Research·2026
Structure of ATTRv-F64S fibrils isolated from skin tissue of a living patient
Nature Communications·2025Open Access
RNF19B confers tumor resistance to CAR T cells
2025Open Access
FCRL3 is an immunoregulatory receptor that restrains the activation of human memory T lymphocytes
The Journal of Experimental Medicine·2025· 1 citedOpen Access
Targeting FOXA1 and FOXA2 disrupts the lineage-specific oncogenic output program in prostate cancer
Universität Zürich, ZORA·2025Open Access
Targeting FOXA1 and FOXA2 disrupts the lineage-specific oncogenic output program in prostate cancer
Cell Reports·2025Open Access
FCRL3 is an immunoregulatory receptor that restrains the activation of human memory T lymphocytes
immuneACCESS·2025
Integrated control of cancer stemness by σ1 receptor in advanced prostate cancer
Oncogene·2025Open Access
TRIM24 Degradation Counteracts Adaptation to Androgen Receptor Inhibition in Prostate Cancer
2025Open Access
Targeting FOXA1 and FOXA2 Disrupts the Lineage-Specific Oncogenic Output Program in Prostate Cancer
2025Open Access
Structure of ATTRv-F64S fibrils isolated from skin tissue of a living patient
2025Open Access
Epigenome-wide impact of MAT2A sustains the androgen-indifferent state and confers synthetic vulnerability in ERG fusion-positive prostate cancer
Nature Communications·2024· 9 citedOpen Access
Crosstalk between Regnase-1 and -3 shapes mast cell survival and cytokine expression
Life Science Alliance·2024· 7 citedOpen Access
High-throughput proteome profiling with low variation in a multi-center study using dia-PASEF
bioRxiv (Cold Spring Harbor Laboratory)·2024· 1 citedOpen Access
Tumor cells express and maintain HMGB1 in the reduced isoform to enhance CXCR4-mediated migration
Frontiers in Immunology·2024· 10 citedOpen Access
Author Reply to Peer Reviews of Crosstalk between the RNA-binding proteins Regnase-1 and -3 shapes mast cell survival and cytokine expression
2024
Author Correction: Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification
Nature Communications·2024Open Access
Inhibition of choline metabolism in an angioimmunoblastic T-cell lymphoma preclinical model reveals a new metabolic vulnerability as possible target for treatment
Journal of Experimental & Clinical Cancer Research·2024· 10 citedOpen Access
Crosstalk between the RNA-binding proteins Regnase-1 and -3 shapes mast cell survival and cytokine expression
2024· 1 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Roger Geiger(18), Matthias Mann(12), Andrea Rinaldi(9), Marco Bolis(7), Andrea Cavalli(6), William M. Keyes(5), Jan Pěnčík(5), Jean‐Philippe Theurillat(5), Gerda Egger(5), Brigitte Hantusch(5), Lukas Kenner(5), Angela M. Krackhardt(5), Carlo V. Catapano(5), Silvia Monticelli(5), Monika Oberhuber(4), Michaela Schlederer(4), Eva Bräunlein(4), Thomas Engleitner(4), Melanie Boxberg(4), Katja Steiger(4)